Blog
RSS FeedPosted by Michael Wonder on 15 Jun 2016
Why cancer can cost more the rarer it is
15 June 2016 - The Pharmaceutical Benefits Scheme is an integral part of the Australian health system. It theoretically provides affordable ...
Posted by Michael Wonder on 14 Jun 2016
Doctor's diary: cancer drugs - hope or hype?
13 June 2016 - When it comes to promoting new cancer therapies, hype springs eternal. But prodigious cost – up to ...
Posted by Michael Wonder on 14 Jun 2016
Medicines information factsheet developed for patients and the public
14 June 2016 - A new information factsheet providing information on how health care professionals decide what medicine is right for ...
Posted by Michael Wonder on 14 Jun 2016
Two new films focus on how SMC works with patient groups
14 June 2016 - To help explain how it works with patient groups to capture and present the patient and carer ...
Posted by Michael Wonder on 14 Jun 2016
NICE recommends laser device to help thousands of men with an enlarged prostate
14 June 2016 - Thousands of men could benefit from laser treatment for an enlarged prostate as recommended in new guidance ...
Posted by Michael Wonder on 13 Jun 2016
Prostate cancer drug decision 'grossly unfair'
13 June 2016 - A charity has said it is "grossly unfair" that men with advanced prostate cancer in Scotland will ...
Posted by Michael Wonder on 13 Jun 2016
Cancer Drugs Fund 2.0: a missed opportunity?
14 June 2016 - The UK National Health Service, like most other developed health care systems, has struggled with how to ...
Posted by Michael Wonder on 13 Jun 2016
Why cancer?
14 June 2016 - Throughout my career as a health economist, one issue has always been a mystery to me—why does ...
Posted by Michael Wonder on 13 Jun 2016
SMC - June 2016 decisions
13 June 2016 - Treatments for Parkinson’s disease, advanced leukaemia and asthma among four new medicines accepted for routine use in ...
Posted by Michael Wonder on 12 Jun 2016
PHARMAC to fund melanoma drug
10 June 2016 - PHARMAC has negotiated a more than $100 million per year saving on the price of six medicines ...
Posted by Michael Wonder on 11 Jun 2016
CADTH calls for patient input on submission from Teva for Fentora (fentanyl citrate)
10 June 2016 - CADTH calls for patient input on a submission from Teva Pharmaceuticals for Fentora (fentanyl citrate). ...
Posted by Michael Wonder on 10 Jun 2016
PHARMAC to seek further advice on azithromycin funding proposal
10 June 2016 - PHARMAC received a number of high-quality, well considered responses to the proposal to amend the funding restrictions ...
Posted by Michael Wonder on 09 Jun 2016
Cancer drug 'a long time coming'
10 June 2016 - PHARMAC has been accused of leaving melanoma patients in suspense by not telling them earlier when their ...
Posted by Michael Wonder on 09 Jun 2016
NICE publishes second appraisal consultation for Nucala (mepolizumab)
9 June 2016 - NICE has published a second appraisal consultation for GSK's Nucala (mepolizumab). ...
Posted by Michael Wonder on 09 Jun 2016
Government announces new drug funding, including for advanced melanoma
9 June 2016 - Medicine to treat six diseases, including for advanced melanoma, will be available to New Zealanders. ...